Get 40% Off
👀 👁 🧿 All eyes on Biogen, up +4,56% after posting earnings. Our AI picked it in March 2024.
Which stocks will surge next?
Unlock AI-picked Stocks

FTSE 100 dips as oil, travel stocks weigh

Published 18/01/2021, 08:22
Updated 18/01/2021, 09:50
© Reuters. FILE PHOTO: Construction work near the River Thames on the Greenwich Peninsula is seen next to the O2 and Canary Wharf financial district in London

By Shivani Kumaresan

(Reuters) - London's FTSE 100 slipped on Monday as a slide in crude oil prices weighed on energy stocks, while tighter restrictions on businesses raised concerns about the near-term economic impact.

The blue-chip FTSE 100 index fell 0.1%, while the domestically focussed mid-cap FTSE 250 index rose 0.3%.

Oil heavyweights BP (LON:BP) and Royal Dutch Shell (LON:RDSa) fell close to 2% each as crude prices slid. [O/R]

Travel and leisure stocks, including British Airways-owner IAG (LON:ICAG), EasyJet and Intercontinental Hotels, shed between 0.8% and 3.2% as all travellers to Britain must have a recent negative COVID-19 test and be prepared to quarantine at home for 10 days on arrival.

Britain's vaccine deployment minister, Nadhim Zahawi, raised concerns about vaccine supply, saying the rollout was limited by "lumpy" manufacturing and Pfizer (NYSE:PFE)'s changes to its production could lead to brief supply disruption.

"Investors will be looking to the speed of vaccine rollout, and the Biden inauguration and what he says about the relationship with UK," said Keith Temperton, a sales trader at Forte Securities.

Meanwhile, foreign minister Dominic Raab said the government hopes to ease some lockdown restrictions in March as it presses ahead with Europe's fastest rollout of COVID-19 vaccines.

The FTSE 100 fell 2% last week after a rally fuelled by Brexit optimism, as investors were worried that more stringent restrictions to curb coronavirus infections might derail prospects of a swift economic recovery from the pandemic-driven recession.

Among individual stocks, drugmaker AstraZeneca rose 0.5% after saying its breast cancer drug received approval as a treatment for a certain type of advanced gastric cancer in the United States.

3rd party Ad. Not an offer or recommendation by Investing.com. See disclosure here or remove ads .

Energy services company Centrica Plc (LON:CNA) lost 2.3% after it said its chief financial officer, Johnathan Ford, would step down on Jan. 31.

Latest comments

what am I going to do now?
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.